Advanced Inhalation Therapies Ltd. (AIT) has announced the completion of a successful financing round, in which it has raised $1.25 million. AIT is developing nitric oxide based treatments for infectious lung diseases. The company says the funds will be used for two clinical trials.
↧
Israeli Lung Treatment Developer AIT Raises $1.25M
↧